So what are the chances the FDA panel approves this?
Volume is very thin here, so expect a super spike into the mid 20's if it is a clear unreserved recommendation. If some reservations but positive rec, expect high teens. Probably will settle in 20 area on unreserved, 16 area with reservations.
Really? You consider $20s a super spike? Did you see what SRPT just did? It shot from $15 to $45 overnight then slid back down into the $30s. A move to $20 isn't even close to a super spike given how small the market cap is on this. It could easily follow the same pattern that SRPT did.
Listen, don't get too greedy. AEGR is going to do fine, probably double from here at approval. But the panel is just a recommendation. SRPT took off after full aproval at PDUFA. After the panel review, sell a third to half your position, then buy back in two weeks. Learn how to play the game.